RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ritodrine Hydrochloride In Dextrose 5% In Plastic Container, and when can generic versions of Ritodrine Hydrochloride In Dextrose 5% In Plastic Container launch?
Ritodrine Hydrochloride In Dextrose 5% In Plastic Container is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER is ritodrine hydrochloride. There are five drug master file entries for this compound. Additional details are available on the ritodrine hydrochloride profile page.
Summary for RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 17 |
Clinical Trials: | 10 |
Formulation / Manufacturing: | see details |
DailyMed Link: | RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assiut University | Phase 3 |
Assiut University | Phase 4 |
Assiut University | N/A |
See all RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
US Patents and Regulatory Information for RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER | ritodrine hydrochloride | INJECTABLE;INJECTION | 071438-001 | Jan 22, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |